Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SID1 transmembrane family member 1 (SIDT1) is a membrane protein composed of 11 transmembrane segments, forming functional homodimers at the plasma membrane. Structurally and functionally related to its C. elegans homolog SID-1, SIDT1 enables uptake of dsRNA and dietary miRNAs, especially under low pH conditions, facilitating systemic RNA interference and posttranscriptional gene silencing. In addition to its RNA transport function, SIDT1 possesses ceramidase enzyme activity, tightly regulated by its interactions with cholesterol via conserved CRAC domains. Cholesterol binding causes conformational changes that modulate lipid hydrolytic activity. SIDT1 is implicated in immune response, tumorigenesis, and chemoresistance (notably involving microRNA-21 in cancer cells). It interacts with RNA and lipid molecules, but no direct pharmacological inhibitors or activators have yet been clinically detailed.
Facilitation of dsRNA/miRNA/siRNA cellular uptake (energy-independent dsRNA transport); Lipid hydrolytic activity modulated by cholesterol binding (ceramidase activity sensitive to allosteric cholesterol regulation)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SID1 transmembrane family member 1 (SIDT1).